Congress Secretariat
c/o JTB Communication Design, Inc. JTB Bldg. 6F, 7F
2-1-25 Kyutaromachi, Chuo-ku, Osaka
541-0056, Japan
E-mail: jshct2021@jtbcom.co.jp

Program

Time Table

Brief Program

* For the full program, Please find more here. *Japanese only

Special LectureSaturday, March 6, 2021, 10:05~10:55

Chair
Masahiro lmamura
(Department of Hematology, Sapporo Hokuyu Hospital)
SL1
History and Future of Allogeneic Hematopoietic Cell Transplantation
Rainer Storb
(Fred Hutchinson Cancer Research Center, Seattle Washington, USA
University of Washington, Seattle, Washington, USA)

Presidential symposiumSaturday, March 6, 2021, 14:30~16:30

Cellular therapies to overcome intractable hematological malignancies-New insight in NK cells
Chair
Junji Tanaka
(Department of Hematology, Tokyo Women’s Medical University)
PSY-1
The role of NK cells in cellular therapy for hematological malignancies
Junji Tanaka
(Department of Hematology, Tokyo Women’s Medical University)
PSY-2
NK Cell Therapy For Hematologic Malignancies: From Individual Donor To Off-The-Shelf NK Products
Jeffrey S. Miller
(University of Minnesota, Department of Medicine, Minneapolis, Minnesota, USA)
PSY-3
Translating NK cell memory as cancer immunotherapy for hematologic malignancies
Todd A. Fehniger
(Division of Oncology, Washington University School of Medicine, USA)
PSY-4
CAR NK cells: a drive to the future of cell therapy
Katy Rezvani
(Department of Stem Cell and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA)

JSHCT-KSBMT Joint SymposiumSunday, March 7, 2021, 9:40~11:20

Transplantation and Cellular Therapy in Elderly Patients
Chair
Takanori Teshima
(Hematology, Hokkaido University)
Hoon Kook
(Chonnam National University Medical School)
JS-1
Cord Blood Transplantation for Elderly Patients with Myeloid Malignancy
Shuichi Taniguchi
(Department of Hematology, Toranomon Hospital)
JS-2
What are the risks and benefits of a transplant for elderly patients?
Sumiko Kobayashi
(Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Department of Hematology)
JS-3
Transplantation in elderly AML
Byung Sik Cho
(Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea)
JS-4
Cellular immunotherapy for Multiple Myeloma: focus on non-CAR T cell
Sung-Hoon Jung
(Department of Hematology and Oncology, Ewha Womans University Seoul Hospital)

Special Educational LectureSunday, March 7, 2021, 14:25~14:55

Chair
Koichi Miyamura
(Department of Hematology, Japanese Red Cross Nagoya First Hospital)
SEL
Progress in the management of acute graft versus host disease
Andrea Bacigalupo
(Institute of Hematology, Catholic University of the Sacred Heart, Agostino Gemel Ii University Hospital Foundation, Rome, Italy)
Page top